SDxCentral23m
Halozyme Proposes €2 Billion Acquisition of Evotec at €11 Per Share
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team Storage-Area Networking (SAN) DIEGO, ...
Halozyme Confirms Proposal To Combine With Evotec For €11.00 Per Share In An All-Cash Transaction
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, ...
Le Lézard58m
Halozyme Confirms Proposal to Combine with Evotec for ?11.00 Per Share in an All-Cash Transaction
Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") confirmed it has submitted a non-binding proposal to the Management Board and Supervisory Board of Evotec SE ("Evotec") to acquire Evotec for ...
Germany’s Evotec Gets Takeover Interest From Halozyme
Germany’s Evotec SE is attracting potential takeover interest from Nasdaq-listed biotech firm Halozyme Therapeutics Inc., people familiar with the matter said.
Halozyme makes 2 billion euro buyout offer for drug developer Evotec
Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), to bulk up its drug discovery and development portfolio.Halozyme ...